The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy

Anticancer agents can effectively treat several types of cancers but are often limited in clinical settings due to various adverse effects. In particular, nausea and vomiting are serious side effects that markedly reduce the patients' quality of life. Accordingly, the development of novel antie...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagawa, Hiroto, Koyama, Yoshihisa, Kobayashi, Yuki, Kobayashi, Hikaru, Shimada, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552029/
https://www.ncbi.nlm.nih.gov/pubmed/36237446
http://dx.doi.org/10.1016/j.bbrep.2022.101363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552029/
https://www.ncbi.nlm.nih.gov/pubmed/36237446
http://dx.doi.org/10.1016/j.bbrep.2022.101363

Ejemplares similares